Antibodies for
Immunohistochemistry
Neurofilament (2F11) 182
NSE (MRQ-55) 183
O
Oct-2 (MRQ-2) 184
Oct-4 (MRQ-10) 185
Olig2 (211F1.1) 186
P
p21
WAF1
(DCS-60.2) 187
p27
Kip1
(SX53G8) 188
p53 (DO7) 189
p57
Kip2
(Kp10) 190
p120 Catenin (MRQ-5) 191
P504s (13H4) 192
Parathyroid Hormone (PTH) (MRQ-31) 193
Parvovirus B19 (R92F6) 194
PAX-2 (Polyclonal) 195
PAX-5 (EP156) 196
PAX-8 (MRQ-50) 197
PD-1 (NAT105) 198
Perforin (MRQ-23) 199
PGP 9.5 (Polyclonal) 200
Phosphohistone H3 (PHH3) (Polyclonal) 201
PLAP (NB10) 202
PMS2 (MRQ-28) 203
Pneumocystis jiroveci (carinii) (3F6) 204
PNL2 (PNL2) 205
Podoplanin (D2-40) 206
Progesterone Receptor (Y85) 207
Prolactin (Polyclonal) 208
PSA (ER-PR8) 209
PSAP (PASE/4LJ) 210
PU.1 (EPR3158Y) 211
R
Renal Cell Carcinoma (PN-15) 212
S
S-100 (4C4.9) 213
SALL4 (6E3) 214
Smoothelin (R4A) 215
Somatostatin (Polyclonal) 216
SOX-2 (SP76) 217
SOX-10 (Polyclonal) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .218
SOX-11 (MRQ-58) 219
Spectrin (RBC2/3D5) 220
SV40 (MRQ-4) 221
Synaptophysin (MRQ-40) 222
T
T-bet (MRQ-46) 223
TAG-72 (B72.3) 224
TCL1 (MRQ-7) 225
TdT (Polyclonal) 226
TFE3 (MRQ-37) 227
Thrombomodulin (1009) 228
Thyroglobulin (MRQ-41) 229
Toxoplasma Gondii (Polyclonal) 230
TRAcP (9C5) 231
Tryptase (G3) 232
TSH (Polyclonal) 233
TTF-1 (8G7G3/1) 234
Tyrosinase (T311) 235
U
Uroplakin III (AU-1) 236
V
Varicella Zoster Virus (SG1-1, SG1-SG4, NCP-1 & IE-62) 237
Villin (CWWB1) 238
Vimentin (V9) 239
W
WT1 (6F-H2) 240
Z
ZAP-70 (2F3.2) 241
Menarini has partnered with Cell Marque Corporation to provide its customers with
the quality IHC products. As partners, Menarini and Cell Marque strive to be complete
and accurate in the presentation of this catalog; however, Menarini, Cell Marque, its
shareholders, its officers, its employees, and its business associates assume no liability
for any reliance on any of the contents of this catalog including but not limited to any
of the antibody panels. Furthermore, Menarini and Cell Marque assume no liability for
any omissions. It is the sole responsibility of laboratories to independently validate the
application and proper use of any product(s) and/or protocol(s). Menarini and Cell Marque
reserve the right to make any changes, additions, and/or deletions to its product offerings
at any time without notice. The antibody panels were constructed based on Cell Marque’s
internal investigations with scores based on the percentage of positivity represented as
follows: “-” for 0-40%, “-/+” for 40-50%, “+/-” for 50-60%, “+” for 60-100%, and blank
for no available data. The products in this catalog are intended for multiple uses (IVD and
RUO).
Product Index
† Rabbit Monoclonals Produced Using Technology
from Epitomics, Inc. Under Patent No. 5,675,063
P
o
w
e
r
e
d
b
y
T
e
c
h
n
o
l
o
g
y
244
